Welcome to Regeneus
Regeneus Ltd (ASX: RGS) is an Australian clinical-stage regenerative medicine company developing a portfolio of novel cellular therapies targeting significant unmet medical needs with a licence driven strategy.
Our initial focus is on osteoarthritis (OA) and other musculoskeletal disorders, neuropathic pain and dermatology. Our allogeneic stem cell and secretions technologies have the ability to be clinically developed to treat multiple indications. The Company’s product pipeline is underpinned by proprietary stem cell technologies.